Literature DB >> 7298179

Effects of pneumolysin on human polymorphonuclear leukocytes and platelets.

M K Johnson, D Boese-Marrazzo, W A Pierce.   

Abstract

Pneumolysin was bound by human polymorphonuclear leukocytes in a reaction which occurred very rapidly at 0 degrees C. Low concentrations of pneumolysin were found to stimulate leukocyte migration and lysosomal enzyme secretion. At increasing lysin levels, inhibition of spontaneous migration and chemotaxis, cell death, and lysis were observed. Pneumolysin was also found to lyse platelets and to activate serum to become chemotactic.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7298179      PMCID: PMC350839          DOI: 10.1128/iai.34.1.171-176.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

1.  Inhibition of leukocyte locomotion and chemotaxis by lipid-specific bacterial toxins.

Authors:  P C Wilkinson
Journal:  Nature       Date:  1975-06-05       Impact factor: 49.962

2.  ELECTRON MICROSCOPE STUDY OF THE DEGRANULATION OF POLYMORPHONUCLEAR LEUKOCYTES FOLLOWING TREATMENT WITH STREPTOLYSIN.

Authors:  D ZUCKER-FRANKLIN
Journal:  Am J Pathol       Date:  1965-09       Impact factor: 4.307

3.  The role of cytolysin in pneumococcal ocular infection.

Authors:  M K Johnson; J H Allen
Journal:  Am J Ophthalmol       Date:  1975-09       Impact factor: 5.258

4.  Suppression of chemotatic activity of human neutrophils by streptolysin O.

Authors:  B R Andersen; D E Van Epps
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

5.  Bacterial factors chemotactic for polymorphonuclear leukocytes.

Authors:  P A Ward; I H Lepow; L J Newman
Journal:  Am J Pathol       Date:  1968-04       Impact factor: 4.307

6.  Biochemical and ultrastructural study of the disruption of blood platelets by streptolysin O.

Authors:  J M Launay; J E Alouf
Journal:  Biochim Biophys Acta       Date:  1979-09-21

7.  Binding of cholesterol by sulfhydryl-activated cytolysins.

Authors:  M K Johnson; C Geoffroy; J E Alouf
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

8.  The secretion of protein by the polymorphonuclear leucocyte treated with streptolysin O.

Authors:  A M Woodin; A A Wieneke
Journal:  Exp Cell Res       Date:  1966-09       Impact factor: 3.905

9.  Properties of purified pneumococcal hemolysin.

Authors:  M K Johnson
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

10.  STUDIES ON LYSOSOMES. III. THE EFFECTS OF STREPTOLYSINS O AND S ON THE RELEASE OF ACID HYDROLASES FROM A GRANULAR FRACTION OF RABBIT LIVER.

Authors:  G WEISSMANN; H KEISER; A W BERNHEIMER
Journal:  J Exp Med       Date:  1963-08-01       Impact factor: 14.307

  10 in total
  29 in total

1.  Effect on polymorphonuclear cell function of a human-specific cytotoxin, intermedilysin, expressed by Streptococcus intermedius.

Authors:  M G Macey; R A Whiley; L Miller; H Nagamune
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

2.  Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia.

Authors:  R B Alcantara; L C Preheim; M J Gentry-Nielsen
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

3.  Effect of Streptococcus pneumoniae on human respiratory epithelium in vitro.

Authors:  C Steinfort; R Wilson; T Mitchell; C Feldman; A Rutman; H Todd; D Sykes; J Walker; K Saunders; P W Andrew
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

4.  Production and purification of Streptococcus pneumoniae hemolysin (pneumolysin).

Authors:  K Kanclerski; R Möllby
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

5.  Modulation of granulocyte functions by bacterial exotoxin and endotoxins.

Authors:  K D Bremm; W König; M Thelestam; J E Alouf
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

6.  The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal disease.

Authors:  Amit Srivastava; Philipp Henneke; Alberto Visintin; Sarah C Morse; Victoria Martin; Claire Watkins; James C Paton; Michael R Wessels; Douglas T Golenbock; Richard Malley
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

7.  Characterization of a recombinant pneumolysin and its use as a protein carrier for pneumococcal type 18C conjugate vaccines.

Authors:  J Kuo; M Douglas; H K Ree; A A Lindberg
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

8.  Inhibition of in vitro human lymphocyte response by the pneumococcal toxin pneumolysin.

Authors:  A Ferrante; B Rowan-Kelly; J C Paton
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

9.  Factors influencing the phagocytosis of Clostridium difficile by human polymorphonuclear leukocytes.

Authors:  D C Dailey; A Kaiser; R H Schloemer
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

10.  Gram-positive bacteria-induced granulocytopenia and pulmonary leukostasis in rabbits.

Authors:  S E Goldblum; W P Reed
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.